当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析

华海药业

(600521)

  

流通市值:201.39亿  总市值:203.55亿
流通股本:14.67亿   总股本:14.83亿

华海药业(600521)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润7.13亿元,每股收益0.50元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益825477.53万元,未分配利润461413.72万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1843142.08万元,负债1017664.56万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入6,207,564,556.194,294,130,016.332,058,913,113.438,265,744,793.28
营业总成本5,237,280,573.213,527,613,095.851,791,603,923.396,635,693,607.64
营业利润924,334,295.14694,035,279.19243,583,809.251,547,171,357.53
利润总额907,967,309.17685,463,564.28240,883,645.681,508,899,776.16
净利润713,177,829.99562,809,707.68168,505,392.261,176,009,472.86
其他综合收益4,225,419.165,496,738.18-2,509,362.69-3,230,019.66
综合收益总额717,403,249.15568,306,445.86165,996,029.571,172,779,453.2
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计7,646,144,887.828,797,779,617.618,180,537,323.187,907,175,521.63
非流动资产合计10,785,275,958.3410,751,927,620.0310,513,830,838.3910,244,561,960.55
资产总计18,431,420,846.1619,549,707,237.6418,694,368,161.5718,151,737,482.18
流动负债合计4,692,584,224.095,570,817,392.694,958,142,435.914,798,554,270
非流动负债合计5,484,061,348.615,524,505,958.415,806,373,903.445,607,562,223.24
负债合计10,176,645,572.711,095,323,351.110,764,516,339.3510,406,116,493.24
归属于母公司股东权益合计8,076,555,134.788,274,115,746.637,734,761,186.957,546,549,238.9
股东权益合计8,254,775,273.468,454,383,886.547,929,851,822.227,745,620,988.94
负债和股东权益合计18,431,420,846.1619,549,707,237.6418,694,368,161.5718,151,737,482.18
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计6,824,884,765.384,575,374,364.682,289,166,502.548,122,287,826.78
经营活动现金流出小计5,373,163,324.533,684,736,970.061,915,233,0736,879,594,699.88
经营活动产生的现金流量净额1,451,721,440.85890,637,394.62373,933,429.541,242,693,126.9
投资活动现金流入小计48,983,8687,045,0822,365,845.978,366,056.79
投资活动现金流出小计1,322,006,264.2944,714,831.07523,470,076.192,510,940,793.75
投资活动产生的现金流量净额-1,273,022,396.2-937,669,749.07-521,104,230.29-2,432,574,736.96
筹资活动现金流入小计2,461,500,0002,240,000,0001,440,000,0003,910,571,278.94
筹资活动现金流出小计3,011,007,996.651,743,499,529.22891,372,507.263,301,528,578.89
筹资活动产生的现金流量净额-549,507,996.65496,500,470.78548,627,492.74609,042,700.05
汇率变动对现金及现金等价物的影响94,725,780.63112,706,613.66-33,857,329.2354,654,378
现金及现金等价物净增加额-276,083,171.37562,174,729.99367,599,362.76-526,184,532.01
期末现金及现金等价物余额1,051,866,953.971,890,124,855.331,695,549,488.11,327,950,125.34
最新报告期:2024-01-26
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
中金公司张琎0.630.760.962024-01-26
中金公司张琎0.630.760.962024-01-26
TOP↑